CCA
AIFF

Cygnus Capital Advisors’s Firefly Neuroscience AIFF Stock Holding History

Cygnus Capital Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44 Buy
+20,039
New +$24.9K 0.03% 76

Other funds holding AIFF

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Cygnus Capital Advisors's AIFF Position: Q1 2026 in Review

Cygnus Capital Advisors opened a new position in Firefly Neuroscience (AIFF) in Q1 2026: 20,039 shares worth $44. The stake represents 0.03% of the portfolio and ranks #76 among its holdings.

23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Cygnus Capital Advisors held 20,039 shares of Firefly Neuroscience worth $44 as of Q1 2026.
  • Firefly Neuroscience was a new Cygnus Capital Advisors position in Q1 2026.
  • Firefly Neuroscience made up 0.03% of Cygnus Capital Advisors's portfolio in Q1 2026, its #76 holding.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Cygnus Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.